These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 3615268)

  • 21. Serum markers of hepatitis B virus and anti-delta antibody in chronic liver disease.
    Buzzelli G; Alterini B; Monaco L; Gialdini D; Baronti E; Matassi L; Simondi P; Zignego AL; Gentilini P
    Quad Sclavo Diagn; 1985 Dec; 21(4):387-98. PubMed ID: 3837913
    [No Abstract]   [Full Text] [Related]  

  • 22. Preference and significance of HBeAg and anti-HBe, determined by enzyme immunoassay, in patients with acute, chronic and resolved hepatitis B.
    Niermeijer P; Gips CH; Huizenga JR; van der Waart M; Schuurs A
    Hepatogastroenterology; 1980 Oct; 27(5):350-5. PubMed ID: 7203369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Detection of HBeAg among HBsAg-positive patients with various hepatic diseases and epidemiologic significance of the findings].
    Xu HW
    Zhonghua Liu Xing Bing Xue Za Zhi; 1983 Aug; 4(4):226-9. PubMed ID: 6640636
    [No Abstract]   [Full Text] [Related]  

  • 24. [R-PHA and PHA methods for the detection of HBeAg and anti-HBe].
    Horiike N; Onji M; Ogawa Y; Kanaoka M; Kajino K; Ohta Y
    Rinsho Byori; 1984 Mar; 32(3):287-90. PubMed ID: 6737740
    [No Abstract]   [Full Text] [Related]  

  • 25. HBeAG and anti-HBe in the Malaysian population and in Malaysian prisoners.
    Ton SH; Lopez CG; Noriah R
    Southeast Asian J Trop Med Public Health; 1983 Jun; 14(2):252-4. PubMed ID: 6635764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Co-existence of HBeAg and anti-HBe in a subject with prolonged hepatitis B].
    Cirelli A; Catania S
    Clin Ter; 1981 Jul; 98(2):215-7. PubMed ID: 7261568
    [No Abstract]   [Full Text] [Related]  

  • 27. [Detecting HBeAg and anti-HBe by ELISA].
    Li CM; Liu CB; Zhang WY; Zhang MC; Li LW
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1984 Jun; 6(3):227-9. PubMed ID: 6241057
    [No Abstract]   [Full Text] [Related]  

  • 28. [HBeAg and anti-HBe in asymptomatic carriers of HBsAg and in various forms of hepatitis and liver cirrhosis].
    Kalinowska B; Nazarewicz-de Mezer T; Krawczyński K
    Przegl Epidemiol; 1984; 38(3):249-56. PubMed ID: 6528039
    [No Abstract]   [Full Text] [Related]  

  • 29. Prevalence of HBeAg and HBsAg seroconversion in patients with chronic hepatitis B.
    Stránský J; Chlumská A; Zichová M; Helm R; Mankovecký L; König J
    Sb Lek; 1993; 94(4):317-25. PubMed ID: 7992018
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Determination of hepatitis B E antigens, anti-hepatitis B E and Dane particles in the serum of hepatitis B S carriers and patients with chronic hepatitis B S antigen-positive hepatitis].
    Reichlin B; Stalder GA; Gudat F; Bianchi L; Froesner GG
    Schweiz Med Wochenschr; 1982 Apr; 112(15):523-4. PubMed ID: 7079688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic carriers of hepatitis B virus in Bangladesh: a comparative analysis of HBV-DNA, HBeAg/anti-HBe, and liver function tests.
    Hasan KN; Rumi MA; Hasanat MA; Azam MG; Ahmed S; Salam MA; Islam LN; Hassan MS
    Southeast Asian J Trop Med Public Health; 2002 Mar; 33(1):110-7. PubMed ID: 12118438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low frequency of precore mutants in anti-hepatitis B e antigen positive subjects with chronic hepatitis B virus infection in Chennai, Southern India.
    Shanmugam S; Velu V; Nandakumar S; Madhavan V; Shanmugasundaram U; Shankar EM; Murugavel KG; Balakrishnan P; Kumarasamy N; Solomon S; Thyagarajan SP
    J Microbiol Biotechnol; 2008 Oct; 18(10):1722-8. PubMed ID: 18955826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of alcohol on the liver in HBsAg carriers.
    Itoh S; Shimoji K
    Am J Gastroenterol; 1986 Sep; 81(9):779-82. PubMed ID: 3752040
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Anti-HBc antibodies in chronic liver diseases].
    Resta ML; Ferraù O; Ajello A; Freni MA; Berlinghieri G; Crinò M; Consolo F
    Boll Soc Ital Biol Sper; 1980 Jul; 56(13):1360-6. PubMed ID: 7448030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparative study of the "e" system (HBeAG/anti-HBeAg) and core antibodies in aggressive chronic hepatitis and liver cirrhosis].
    Marinucci G; Muglia M; Di Giacomo C; Petrucci L; Mancini R; Costa F; Bachetoni A
    Quad Sclavo Diagn; 1981 Mar; 17(1):81-5. PubMed ID: 7313073
    [No Abstract]   [Full Text] [Related]  

  • 36. Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B.
    Hsu YS; Chien RN; Yeh CT; Sheen IS; Chiou HY; Chu CM; Liaw YF
    Hepatology; 2002 Jun; 35(6):1522-7. PubMed ID: 12029639
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HBeAg and anti-HBe in chronic hepatitis B virus infection.
    Chen DS; Sung JL; Lai MY
    Gastroenterology; 1981 Apr; 80(4):880-2. PubMed ID: 7202958
    [No Abstract]   [Full Text] [Related]  

  • 38. [The significance of studying the HBe system in the prognosis of patients with acute and chronic viral hepatitis Be].
    Perisić-Savić M; Nastić-Mirić D
    Srp Arh Celok Lek; 1983; 111(9-10):1343-50. PubMed ID: 6681452
    [No Abstract]   [Full Text] [Related]  

  • 39. [Follow-up of chronic hepatitis B carriers. Serological course and risk of reactivation].
    Bujanda L; García Bengoechea M; Cilla G; Gil I; yArenas JI
    Rev Esp Enferm Dig; 1996 May; 88(5):335-9. PubMed ID: 8764540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation between HBeAg/anti-HBe and other hepatitis B virus (HBV) markers in healthy carriers.
    Musca A; Cordova C; Barnaba V; Zaccari C
    Quad Sclavo Diagn; 1981 Sep; 17(3):363-9. PubMed ID: 7343989
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.